# Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)

> **NCT03645603** · PHASE2 · TERMINATED · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 45 (actual)

## Conditions studied

- Withdrawal Syndrome

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03645603
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-30
- **Primary completion:** 2020-01-18
- **Final completion:** 2020-01-18
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** futility reasons
- **Last updated:** 2021-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03645603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03645603, "Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03645603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*